Precision Strike: Targeting Tumors with Light

Researchers are exploring a cutting-edge cancer treatment that utilizes light-sensitive compounds to selectively destroy tumor cells. This innovative method, known as photodynamic therapy (PDT), is gaining traction as a potential game-changer in oncology.

Unlike conventional cancer treatments like chemotherapy and radiation,which can harm healthy cells alongside cancerous ones,PDT aims to minimize collateral damage. The core principle involves administering a photosensitizing agent that accumulates in tumor tissue. when exposed to a specific wavelength of light, this agent becomes activated, triggering a cascade of events that lead to the destruction of cancer cells.

Cyanine-Carboran Salts: A new Generation of Photosensitizers

A collaborative effort between scientists at Michigan State University (MSU) and the University of california, Riverside (UCR) has yielded promising results with a new class of compounds called cyanine-carboran salts. These salts are designed to be highly selective, targeting and eradicating aggressive breast cancer cells while sparing healthy tissue.

The research team, led by MSU’s Sophia Lunt and richard Lunt, along with UCR’s Vincent Lavallo, is focusing on refining these compounds to maximize their efficacy and minimize potential side effects. Their work represents a significant step forward in the advancement of targeted cancer therapies.

The Science Behind the Salts: How They Work

Cyanine-carboran salts are activated by infrared light, which has the ability to penetrate deeper into the body compared to other wavelengths.Onc activated, these salts act as “smart bombs,” selectively destroying cancer cells while leaving surrounding healthy cells unharmed. This targeted approach is a key advantage over traditional PDT methods.

our innovative cyanine-carboran salts provide a targeted option with reduced side effects for patients with aggressive breast cancer. We expect this research to lead to safer and more effective therapies for patients with limited treatment options.
Sophia Lunt, Michigan State University

Advantages Over Traditional Photodynamic Therapy

Current FDA-approved PDT drugs can linger in the body, making patients highly sensitive to light for extended periods. this often requires patients to avoid sunlight for weeks or even months after treatment to prevent skin blistering and burns. The new cyanine-carboran salts offer a significant improvement in this regard.

The PDT chemicals approved by the FDA remain in other parts of the body, such as the skin, for long periods of time. After traditional PDT treatment, the patient should stay in the dark for two to three months, because even low levels can cause blisters and burns on the skin.
Hyllana Medearos, Postdoctoral Researcher

by being more readily absorbed by cancer cells and cleared from the body, these salts reduce the risk of prolonged photosensitivity and associated side effects.

Beyond Breast Cancer: Potential for wider Submission

While the initial focus is on aggressive breast cancer, researchers believe that cyanine-carboran salts hold promise for treating other types of cancer as well. The targeted delivery mechanism could also be adapted for delivering other types of drugs directly to cancer cells,further enhancing treatment efficacy.

Our work provides effective treatment for aggressive breast cancer forms. It also opens the door to revolutionary discoveries for treatments of other types of cancer and targeted delivery of drugs.
Amir Roshanzadeh, Michigan State University

The team is currently exploring the effectiveness of these salts against various cancer types, paving the way for a broader range of applications.

The Power of Collaboration: A Multidisciplinary Approach

The success of this research highlights the importance of interdisciplinary collaboration in tackling complex challenges like cancer. By bringing together experts in cancer biology,chemistry,and engineering,the team has been able to develop a truly innovative approach to cancer treatment.

The truly innovative discoveries that allow solutions for complex problems such as cancer require interdisciplinary teams such as ours.This research is a perfect example of what can be done when combining researchers with different backgrounds, in areas such as cancer biology, chemistry and scientific engineering; good things happen.
Richard Lunt,Michigan State University